A sign on the wall of Panthera Biopartners’ head office in Preston declares it to be ‘shaping a healthier future’. It is no idle boast.
In a recent interview with Lancashire Business View, Panthera Biopartners CEO Stuart Young highlighted the company’s transformative role in clinical research and its ambitious vision for the future of medical science. Young discussed how Panthera is accelerating the development of new treatments by expanding access to trials through its network of community-based research sites. He emphasised Panthera’s innovative approach to patient recruitment and site management, which is helping sponsors bring therapies to market faster and more efficiently. Looking ahead, Young reaffirmed Panthera’s commitment to being a key player in the evolution of global clinical research.
Read the full interview to learn more about Panthera’s mission and future direction